↓ Skip to main content

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

Overview of attention for article published in Journal of Neuro-Oncology, February 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
facebook
1 Facebook page

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
55 Mendeley
Title
Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma
Published in
Journal of Neuro-Oncology, February 2019
DOI 10.1007/s11060-019-03116-z
Pubmed ID
Authors

Antonio Silvani, Irene De Simone, Vittorio Fregoni, Elena Biagioli, Enrico Marchioni, Manuela Caroli, Andrea Salmaggi, Andrea Pace, Valter Torri, Paola Gaviani, Erica Quaquarini, Giorgia Simonetti, Eliana Rulli, Maurizio D’Incalci

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 55 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 13%
Student > Doctoral Student 4 7%
Student > Bachelor 4 7%
Professor > Associate Professor 3 5%
Student > Master 3 5%
Other 9 16%
Unknown 25 45%
Readers by discipline Count As %
Medicine and Dentistry 14 25%
Neuroscience 6 11%
Philosophy 2 4%
Nursing and Health Professions 2 4%
Social Sciences 1 2%
Other 2 4%
Unknown 28 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2019.
All research outputs
#14,438,902
of 23,128,387 outputs
Outputs from Journal of Neuro-Oncology
#1,830
of 2,996 outputs
Outputs of similar age
#236,969
of 437,541 outputs
Outputs of similar age from Journal of Neuro-Oncology
#46
of 77 outputs
Altmetric has tracked 23,128,387 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,996 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 36th percentile – i.e., 36% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,541 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.